Navigation Links
Medicis Pharmaceutical company enters pediatric market

Medicis is the leading independent pharmaceutical company in the United States focusing primarily on the treatment of dermatological conditions. Based in Wilmington, Mass., Ascent is a pharmaceutical company primarily dedicated to the specialty of pediatrics. Medicis Pharmaceutical Corporation and Ascent Pediatrics, Inc. today announced that they have entered into a definitive merger agreement under which Medicis will acquire Ascent, a specialty pharmaceutical company focused on the marketing and sale of prescription products to U.S. based pediatricians. //

Under the terms of the agreement, Medicis will pay approximately $60 million and has agreed to pay to the holders of Ascent's common equity up to an additional $10 million per year for each of the first five years. This transaction provides Medicis with critical mass to assist with the entrance into the category of pediatrics.

"We are pleased to announce our carefully planned entrance into the pediatric market with a transaction we expect to be accretive," said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. Emmett Clemente, Ph.D., Chairman, President and Treasurer of Ascent said, "We at Ascent are extremely pleased to have entered into this arrangement as it provides us the best opportunity to transfer the mission of Ascent to a strong and innovative organization, which can provide the pediatric community with creative and valuable products. "

Ascent's portfolio of specialty pharmaceutical pediatric products currently includes ORAPRED? (prednisolone sodium phosphate), PRIMSOL? (trimethoprim HCl), and PEDIAMIST?. Sales of ORAPRED? comprise the majority of the Ascent product sales. Ascent currently supports these products with a dedicated pediatric sales force, numbering approximately 70 representatives and sales management.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical companies are targeting patients
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
7. Pharmaceutical industries grant for R&D to be monitored
8. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Top Pharmaceuticals Influence Doctors Prescriptions
Post Your Comments:
(Date:12/2/2008)...e/ -- The Healthcare group at Frost & Sullivan...to announce that it will be,hosting an interactiv...iology,Markets on 11 December 2008 at 3pm GMT. ,.../20081117/FSLOGO ) , With most diagnostic c...dors in Europe are faced with an immense challenge...
(Date:12/2/2008)...e/ -- Services form an integral part of most of,o... It has therefore become,essential for service pr...market to remain competitive and constantly improv..., (Logo: http://www.newscom.com/cgi-bin/p...rost & Sullivan ( http://www.medicalimaging.fr...
(Date:12/2/2008)...ec. 2 Internationally recognized,...vited speaker for this,year,s annual meeting of t...(Photo: http://www.newscom.com/cgi-bin/prnh/2008...minimally invasive (or ,Goldilocks,) anesthesia,i... 101, minimally invasive,anesthesia for minimally...
(Date:12/2/2008)... SPEAK to collect and disseminate pharmacy experie...levue, Wash. (PRWEB) December 2, 2008 -- Pharmacy...new initiative to focus public and industry attent... kick-off of SPEAK will occur during the American ...idyear Clinical Meeting, to be held December 7-11 ...
Breaking Medicine News(10 mins):Health News:Will Diagnostic Cardiology Vendors Look to Product Innovation? 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2
...e advocacy group, Families USA, suggests that majo...lion, have at least one parent employed full-time/...d to be earning members. The group's executive di... believe these are low-income people who don't wor...
...t people suffering a severe personality disorder a...tal Health Services are putting their best foot fo...The 1959 Mental Health Act has indicated that chro...nged stay in Mental Healthcare Hospitals, if their...
... up your socks and make healthy lifestyle changes....s growing at epidemic proportions//. Apart from ov...se, it is also the cause of many chronic illnesses...me alarming statistics; nearly one-third of 500,00...
...due to Japanese encephalitis, the death toll since...rict.// According to the Additional Director (Hea...ng illness have been reported from several parts o...Wednesday evening. Mr. Prasad said that 74 people...
Other Medicine News:
(Date:12/1/2008)... research has found that the availability of a por... in an emergency room can significantly increase t...lly life-saving treatment. Results of the study, c...m Hospital in Salem, Mass., will be presented toda...y of North America (RSNA). , , "The hospita...
(Date:12/1/2008)...USNewswire/ -- A study has found that positron emi...ng the breast, is not affected by either breast de...at limit the effectiveness of standard mammography...ented today at the annual meeting of the Radiologi...The ability of PEM to detect cancer does not appea...
(Date:12/1/2008)...-- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) re...d,s leading medical journals, results of clinical ...tal compound tasimelteon (VEC-162). The publicati...gonist tasimelteon (VEC-162) for transient insomni...d multicentre trials." Results are reported from t...
(Date:12/1/2008)... announced that an oral,presentation of prelimin...,trial of TG101348 in myeloproliferative disease ...Society of Hematology (ASH) Meeting. , , De...itle: A Phase I Study of TG101348, an...-Selective Inhibitor, in Patients with, ...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Iomai Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today 6099 1Iomai Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today 6099 2eRT Announces the Availability of the Suicidality Monitoring System 28TM 29 For Clinical Trials 2474 1eRT Announces the Availability of the Suicidality Monitoring System 28TM 29 For Clinical Trials 2474 2eRT Announces the Availability of the Suicidality Monitoring System 28TM 29 For Clinical Trials 2474 3 5Bvideo 5D WallSt nets 3 Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following 3A DAI OPXA AIRN BCLI GTEC 22276 1 5Bvideo 5D WallSt nets 3 Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following 3A DAI OPXA AIRN BCLI GTEC 22276 2 5Bvideo 5D WallSt nets 3 Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following 3A DAI OPXA AIRN BCLI GTEC 22276 3Caregiverlist com Helps Families Find Quality Senior Care 22273 1Caregiverlist com Helps Families Find Quality Senior Care 22273 2
...nite to Help Educate on Good,Diabetes Management a...Problems, SEATTLE, April 10, 2007 /PRNewswire/ -- ...ce and cost of type 2 diabetes,complications shows...percent) with type 2 diabetes have at least one of...ated with the disease, and,that these health probl...
...cal utilization management,programs, ST. PAUL, Min...t,manager Prime Therapeutics (Prime) today announc...rattera(R) (atomoxetine) for treating,attention de...he,study found that children who start on Stratter...py than children who started on,stimulants. Due to...
Other Medicine Technology:First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)
...single plane C-arm angiography system is designed ...mance and an expansive range of diagnostic and int...y to ECG triggered. Outstanding image quality ...ynamic Flat Detector technology, high frequency X-...
...ronystagmography) is a complete vestibular diagnos...eye movements collected via electrodes. Its Window...cade, tracking and Slow Phase Velocity analyses ar...aphic comparison of results to normative data. A p...
Medicine Products: